Table 1.
Patient characteristics
| Subject characteristics | Number of patients | % |
|---|---|---|
| Age | ||
| ≤50 | 94 | 44.3 |
| >50 | 118 | 55.7 |
| Gender | ||
| Female | 54 | 25.5 |
| Male | 158 | 74.5 |
| Histologic type | ||
| Keratinizing squamous cell carcinoma | 4 | 1.9 |
| Nonkeratinizing carcinoma | 208 | 98.1 |
| T stage | ||
| T1 | 30 | 14.1 |
| T2 | 68 | 32.1 |
| T3 | 68 | 32.1 |
| T4 | 46 | 21.7 |
| N stage | ||
| N0 | 5 | 2.4 |
| N1 | 38 | 17.9 |
| N2 | 130 | 61.3 |
| N3 | 39 | 18.4 |
| AJCC stage | ||
| I | 4 | 1.9 |
| II | 27 | 12.7 |
| III | 102 | 48.1 |
| IV | 79 | 37.3 |
| Radiotherapy | ||
| Median dose (Gy) | 70 | |
| Range (Gy) | 66-74 | |
| Chemotherapy | ||
| No | 17 | 8.0 |
| Induction | 12 | 5.7 |
| Concurrent | 11 | 5.2 |
| Induction+ Concurrent | 34 | 16.0 |
| Concurrent+adjuvant | 51 | 24.1 |
| Induction+ adjuvant | 24 | 11.3 |
| Induction+ Concurrent+ adjuvant | 63 | 29.7 |